Integra LifeSciences
In Howard Marks's portfolio · Oaktree Capital Management
Ticker IART.CV
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Oaktree Capital Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q1 2013 | Reduce 4% | 52,388,000 | 1.1% |
| Q4 2012 | Reduce 5% | 54,788,000 | 1.0% |
| Q3 2012 | Buy | 57,388,000 | 1.0% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.